Last reviewed · How we verify
CM518D1
At a glance
| Generic name | CM518D1 |
|---|---|
| Sponsor | Keymed Biosciences Co.Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of CM518D1 in Patients With Advanced Solid Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CM518D1 CI brief — competitive landscape report
- CM518D1 updates RSS · CI watch RSS
- Keymed Biosciences Co.Ltd portfolio CI